Position in ZYME
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,018,056
-$91,028 QoQ
Shares Held
320,210
+4.0% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. ZYME ranks #115 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ZYME
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,018,056 | 320,210 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $8,109,084 | 307,979 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,948,158 | 348,253 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,389,975 | 349,799 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,608,250 | 386,923 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,780,310 | 394,830 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,655,132 | 370,927 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,101,161 | 364,414 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,399,968 | 418,248 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,334,145 | 417,146 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,661,956 | 419,867 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,637,681 | 421,028 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $271,914 | 30,079 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $100,859 | 12,832 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||